105 related articles for article (PubMed ID: 30529791)
21. The dual CCR2/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice.
Liang F; Giordano C; Shang D; Li Q; Petrof BJ
PLoS One; 2018; 13(3):e0194421. PubMed ID: 29561896
[TBL] [Abstract][Full Text] [Related]
22. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
[TBL] [Abstract][Full Text] [Related]
23. Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy.
Miglietta D; De Palma C; Sciorati C; Vergani B; Pisa V; Villa A; Ongini E; Clementi E
Orphanet J Rare Dis; 2015 Aug; 10():101. PubMed ID: 26296873
[TBL] [Abstract][Full Text] [Related]
24. Weekly oral prednisolone improves survival and strength in male mdx mice.
Keeling RM; Golumbek PT; Streif EM; Connolly AM
Muscle Nerve; 2007 Jan; 35(1):43-8. PubMed ID: 16969833
[TBL] [Abstract][Full Text] [Related]
25. Chronic effects of losartan on the muscles and the serologic profiles of mdx mice.
Lee EM; Kim DY; Kim AY; Lee EJ; Kim SH; Lee MM; Sung SE; Park JK; Jeong KS
Life Sci; 2015 Dec; 143():35-42. PubMed ID: 26497927
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
[TBL] [Abstract][Full Text] [Related]
27. Circulating serum CK level vs. muscle impairment for in situ monitoring burden of disease in Mdx-mice.
Klein SM; Prantl L; Geis S; Felthaus O; Dolderer J; Anker AM; Zeitler K; Alt E; Vykoukal J
Clin Hemorheol Microcirc; 2017; 65(4):327-334. PubMed ID: 27716655
[TBL] [Abstract][Full Text] [Related]
28. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
29. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice hearts at later stages of dystrophy.
Fogagnolo Mauricio A; Pereira JA; Santo Neto H; Marques MJ
Nutrition; 2016; 32(7-8):855-62. PubMed ID: 27134205
[TBL] [Abstract][Full Text] [Related]
30. Pre-treatment with Pamidronate Improves Bone Mechanical Properties in Mdx Mice Treated with Glucocorticoids.
Chen J; Yoon SH; Grynpas MD; Mitchell J
Calcif Tissue Int; 2019 Feb; 104(2):182-192. PubMed ID: 30302533
[TBL] [Abstract][Full Text] [Related]
31. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: A comparison with the gold standard, α-methyl prednisolone.
Capogrosso RF; Cozzoli A; Mantuano P; Camerino GM; Massari AM; Sblendorio VT; De Bellis M; Tamma R; Giustino A; Nico B; Montagnani M; De Luca A
Pharmacol Res; 2016 Apr; 106():101-113. PubMed ID: 26930420
[TBL] [Abstract][Full Text] [Related]
32. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling.
Acuña MJ; Pessina P; Olguin H; Cabrera D; Vio CP; Bader M; Muñoz-Canoves P; Santos RA; Cabello-Verrugio C; Brandan E
Hum Mol Genet; 2014 Mar; 23(5):1237-49. PubMed ID: 24163134
[TBL] [Abstract][Full Text] [Related]
33. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
[TBL] [Abstract][Full Text] [Related]
34. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
Bozycki L; Łukasiewicz K; Matryba P; Pikula S
Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
[TBL] [Abstract][Full Text] [Related]
35. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
36. Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle.
Hermes Tde A; Macedo AB; Fogaça AR; Moraes LH; de Faria FM; Kido LA; Cagnon VH; Minatel E
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):259-67. PubMed ID: 26639107
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy.
Yoon SH; Chen J; Grynpas MD; Mitchell J
Bone; 2016 Sep; 90():168-80. PubMed ID: 27373502
[TBL] [Abstract][Full Text] [Related]
38. Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.
Pereira JA; Marques MJ; Santo Neto H
Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):788-94. PubMed ID: 25959722
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy.
Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ
Hum Mol Genet; 2015 Apr; 24(8):2147-62. PubMed ID: 25552658
[TBL] [Abstract][Full Text] [Related]
40. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.
Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ
J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
